Nutriband (NASDAQ:NTRB – Get Free Report) is expected to release its earnings data before the market opens on Friday, May 30th. Analysts expect Nutriband to post earnings of ($0.13) per share and revenue of $0.71 million for the quarter.
Nutriband (NASDAQ:NTRB – Get Free Report) last released its quarterly earnings data on Monday, April 28th. The company reported ($0.18) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.06). Nutriband had a negative return on equity of 54.49% and a negative net margin of 338.51%. The firm had revenue of $0.64 million during the quarter, compared to analyst estimates of $0.71 million. On average, analysts expect Nutriband to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Nutriband Stock Up 9.1%
NTRB stock opened at $5.98 on Wednesday. The company has a quick ratio of 4.83, a current ratio of 4.96 and a debt-to-equity ratio of 0.01. Nutriband has a fifty-two week low of $3.72 and a fifty-two week high of $11.78. The firm’s 50-day simple moving average is $5.65 and its 200 day simple moving average is $5.67. The stock has a market cap of $66.70 million, a PE ratio of -8.42 and a beta of 1.18.
About Nutriband
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
Featured Stories
- Five stocks we like better than Nutriband
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Beaten-Down Stocks Trading 50% Below Their 52-Week Highs
- Investing In Automotive Stocks
- Tesla: Why Analysts Think It Could Jump Another 47%
- What Are Dividend Challengers?
- Microsoft’s Outlook Brightens as Analysts Boost Bullish Ratings
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.